Table 2 Summary odds ratio (per allele) and 95% confidence interval for risk of invasive epithelial ovarian cancer among the indicated OCAC studies for SNPs that showed no association with ovarian cancer

From: Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium

Gene

SNP

Controls ( N)

Cases ( N)

OR het a (95% CI)

P -value

OR hom a (95% CI)

P -value

Studies

COMT

rs4680

874

381

1.01 (0.75–1.36)

0.96

1.00 (071–1.42)

0.98

HAWAII, MAYO OVCARE

CYP1A1

rs4646903

1182

490

1.15 (0.89–1.50)

0.29

0.77 (0.28–2.13)

0.61

HAWAII, NECC, OVCARE

CYP1A1

rs1048943

1308

611

1.13 (0.79–1.63)

0.50

0.97

HAWAII, MAYO, NECC, OVCARE

CYP1B1

rs1056836

875

384

0.91 (0.69–1.21)

0.52

0.83 (0.58–1.19)

0.31

HAWAII, MAYO OVCARE

CYP17

rs743572

1594

1078

1.09 (0.91–1.30)

0.36

1.19 (0.93–1.52)

0.17

HAWAII, NCOCS, NECC, SWH, USC

ESR2

rs3020450

2198

1523

0.95 (0.83–1.10)

0.52

1.09 (0.87–1.36)

0.44

HAWAII, NCOCS, NECC, USC

XRCC3

rs861539

5186

2352

0.92 (0.82–1.04)

0.17

1.01 (0.85–1.19)

0.95

AOCS, MALOVA, NCOCS, SEARCH, GEOCS, SWH

  1. aCI=confidence interval; het=heterozygous carriers; hom=homozygous carriers; OR=odds ratio. All ORs stratified on study site, race/ethnicity and age.